Verticillin A (13) sensitized metastatic human colon carcinoma cells to Fas-mediated apoptosis, exhibiting greater efficacy than decitabine and vorinostat, increasing also death receptor 5 (DR5) expression to effectively overcome resistance to DR5 agonist drozitumab-induced apoptosis [83]. The gene discussed is FAS; the disease is colon carcinoma.